terlipressin has been researched along with Liver Cirrhosis in 195 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (3.59) | 18.7374 |
| 1990's | 20 (10.26) | 18.2507 |
| 2000's | 61 (31.28) | 29.6817 |
| 2010's | 73 (37.44) | 24.3611 |
| 2020's | 34 (17.44) | 2.80 |
| Authors | Studies |
|---|---|
| Chandran, P; Jain, G; Patel, NB; Patnaik, I | 1 |
| Velez, JCQ | 1 |
| Andraus, W; Arantes, RM; Carneiro-D'albuquerque, LA; Cunha, MR; De Moura, EG; Ducatti, L; Ernani, L; Fernandes, MR; Galvão, FH; Martino, RB; Nacif, LS; Pereira, PB; Pinheiro, RS; Rocha-Santos, V; Waisberg, DR | 1 |
| Curry, MP; Jamil, K; Pappas, SC; Reddy, KR; Sanyal, A; Vargas, H; Wong, F | 1 |
| Ahn, J; Flamm, SL; Kamath, PS; Wong, F | 1 |
| Nanchal, RS; Warrillow, S | 1 |
| Angeli, P; Basso, D; Brocca, A; Burra, P; Calvino, V; Cillo, U; Cosma, C; Gagliardi, R; Gambino, C; Incicco, S; Piano, S; Stenico, M; Tonon, M; Zaninotto, M; Zeni, N | 1 |
| Arora, V; Choudhary, SP; Jindal, A; Kumar, G; Maiwall, R; Sarin, SK; Vijayaraghavan, R | 1 |
| Kwo, P; Wong, F | 1 |
| Allegretti, AS; Belcher, JM; Kanduri, SR; Karakala, N; Kovacic, RA; Mohamed, MMB; Regner, KR; Tayebi, K; Therapondos, G; Velez, JCQ; Wentowski, C; Wickman, TJ | 1 |
| Aschenbach, R; Franken, P; Platzer, S; Ripoll, C; Schuhmacher, U; Stallmach, A; Steighardt, J; Teichgräber, U; Wienke, A; Zipprich, A | 1 |
| Parikh, ND; Tapper, EB | 1 |
| Belcher, JM | 1 |
| Bass, SN; Kapoor, A; Lindenmeyer, CC | 1 |
| Jin, X; Pan, X; Shi, D; Zhou, Z | 1 |
| Cheng, DY; Ou, WN; Wan, G; Xing, HC | 1 |
| Mohanty, A | 1 |
| Liu, CH; Wang, J; Xing, F | 1 |
| Héra, L; Molnár, P; Páll, I; Rácz, S; Sahin, P; Sebők, A; Újhelyi, P | 1 |
| Dev, D; Krishna, R; Prasad, SC; Raj, J; Reghu, R; V, SO | 1 |
| An, Y; Bai, Z; Guo, X; Li, H; Méndez-Sánchez, N; Qi, X; Teschke, R | 1 |
| Bernardi, M; Chen, Y; Li, B; Li, Y; Lin, S; Liu, B; Meng, F; Qi, X; Shao, L; Tang, S; Wu, Y; Xu, X; Yang, Y; Yoshida, EM; Yuan, S; Zhu, Q | 1 |
| Angus, PW; Chapman, B; Gow, PJ; Sinclair, M; Terbah, R; Testro, AG; Thwaites, PA | 1 |
| Bainbridge, A; Chouhan, MD; Davies, N; Halligan, S; Lythgoe, MF; Mookerjee, RP; Taylor, SA; Walker-Samuel, S | 1 |
| Arab, JP; Benítez, C; Kulkarni, AV; Kumar, P; Premkumar, M; Rao, PN; Reddy, DN; Sharma, M; Simonetto, DA; Tirumalige Ravikumar, S | 1 |
| De, A; Mehtani, R; Singh, V | 1 |
| Busta Nistal, MR; Fernández Salazar, L; Mora Cuadrado, N | 1 |
| Curry, MP; Escalante, S; Frederick, RT; Gonzalez, SA; Jamil, K; Lim, N; Mayo, MJ; Mumtaz, K; Pappas, SC; Porayko, MK; Reddy, KR; Rubin, RA; Sanyal, AJ; Sharma, P; Simonetto, DA; Wong, F | 1 |
| Garcia-Tsao, G | 1 |
| Brañez-Condorena, A; García-Gomero, D; Huaman, MR; Huaringa-Marcelo, J; Lozano Miranda, A; Montes-Teves, P; Pinto-Ruiz, DF; Urday-Ipanaqué, D; Villacorta-Landeo, P | 1 |
| Andria, I; Surace, M; Valentini, G | 1 |
| Brown, K; Brown, RS; Burra, P; Flamm, SL; Kugelmas, M; Poordad, F; Saab, S; Samaniego-Picota, M; Wadei, HM | 1 |
| Lindenmeyer, CC; Sundaram, V; Vipani, A | 1 |
| Gadano, A; Garcia-Olveira, L; Mauro, E | 1 |
| Francoz, C; Khemichian, S; Nadim, MK | 1 |
| Chawla, YK; Taneja, S | 1 |
| Baiges, A; Berbel, C; García-Pagán, JC; Hernández-Gea, V | 1 |
| Alam, A; Butt, AK; Haq, IU; Malik, K; Salim, A | 1 |
| Angeli, P; Piano, S; Tonon, M | 1 |
| Gow, P; Papaluca, T | 1 |
| Baltayiannis, G; Christaki, M; Christodoulou, D; Christou, L; Kalambokis, GN; Koustousi, C; Tsiakas, I | 1 |
| Anapaz, V; Carvalho E Branco, J; Reis, J; Santos, L | 1 |
| Chen, G; Han, MF; Jiang, QQ; Kilonzo, SB; Ma, K; Ning, Q; Wan, XY; Wang, YL; Wu, WY; You, J | 1 |
| Jia, JD; Qi, XS; Zhou, XM | 1 |
| Angeli, P; Ginès, P; Kamath, PS; Nadim, MK; Solà, E; Wong, F | 1 |
| Han, B; Han, D; Liu, F; Qi, X; Shao, L; Song, T; Tripathi, D; Zhou, X; Zhu, J | 1 |
| Carol, M; Cereijo, U; dePrada, G; Fabrellas, N; Farrés, J; Ginès, P; Graupera, I; Huelin, P; Jiménez, W; Juanola, A; Mas, JM; Morales-Ruiz, M; Moreira, R; Napoleone, L; Pose, E; Solà, E; Solé, C; Torres, F | 1 |
| Chiang, CW; Huang, YB; Lin, YJ | 1 |
| Galle, PR; Jäger, J; Labenz, C; Marquardt, JU; Nagel, M; Nguyen-Tat, M; Rey, JW; Wörns, MA | 1 |
| Bai, W; Cai, H; Chen, H; Fan, D; Guo, W; Han, G; Han, N; He, C; Li, K; Li, T; Li, X; Liu, L; Luo, B; Lv, Y; Niu, J; Wang, E; Wang, J; Wang, Q; Wang, Z; Wu, K; Xia, D; Xia, J; Xie, H; Yang, Z; Yao, L; Yin, Z; Yu, T; Yuan, J; Yuan, X; Zhang, H; Zhu, Y | 1 |
| Hsu, SJ; Huang, HC | 1 |
| Bendtsen, F; Egerod Israelsen, M; Gluud, LL; Krag, AA; Møller, S | 1 |
| Ahmed, F; Ali, L; Haider, S; Hussain, Q; Liaquat, H; Shahbaz, S; Solangi, NM | 1 |
| Lee, HJ; Oh, MJ | 1 |
| Aytan, P; Erdemır, F; Kisacik, B; Köseoğlu, RD; Kutlutürk, F; Taşliyurt, T; Yelken, BM; Yilmaz, A | 1 |
| Brito, J; Ferreira, AO; Rosa, L; Sousa, HT | 1 |
| Guntipalli, P; Rahimi, RS; Rockey, DC | 1 |
| Chen, LT; Hwang, DY; Hwang, SJ; Kuo, MC; Wang, SS; Wang, YK | 1 |
| Pasechnik, IN; Sal'nikov, PS | 1 |
| Blokhina, NV; Pasechnik, IN | 1 |
| Choi, JH; Choung, RS; Hyun, JJ; Jung, SW; Kim, HR; Koo, JS; Lee, HJ; Lee, SJ; Lee, SW; Lee, YS; Ryu, JY; Yim, HJ; Yoon, EL | 1 |
| Egerod Israelsen, M; Gluud, LL; Krag, A | 1 |
| Peng, J; Wan, S; Wan, X; Zhu, Q | 1 |
| Ahrens, J; Galle, PR; Götz, E; Marquardt, JU; Nguyen-Tat, M; Rey, JW; Schattenberg, J; Scholz-Kreisel, P; Sivanathan, V; Wörns, MA | 1 |
| Gupta, N; Kumar, A; Mittal, VV; Sarin, SK; Sharma, P | 1 |
| Angeli, P; Cavallin, M; Fasolato, S; Marenco, S; Piano, S; Tonon, M | 1 |
| Boyer, TD; Frederick, RT; Ganger, D; Jamil, K; Lake, JR; O'Leary, JG; Pappas, SC; Sanyal, AJ; Wong, F | 1 |
| Paďour, F; Pokorný, M; Šíma, M; Slanař, O | 1 |
| Wong, F | 2 |
| Edrees, AM; El-Abd, OL; El-Azab, GI; El-Said, HH; Salman, TA | 1 |
| Ginès, P | 1 |
| Buder, R; Lenz, K; Lohr, G; Piringer, P; Voglmayr, M | 1 |
| Bertino, G; Crisafulli, E; Demma, S; Koukias, N; Privitera, G; Purrello, F; Spadaro, L; Tsochatzis, EA | 1 |
| Hsieh, YH; Hung, TH; Tsai, CC; Tseng, CW; Tseng, KC | 1 |
| Charrabi, A; Colson, PH; Corbani, M; Gaudard, P; Guillon, G; Manière, MJ; Richard, S; Virsolvy, A | 1 |
| Bhadoria, AS; Choudhury, A; Joshi, YK; Kedarisetty, CK; Kumar, G; Kumar, S; Maiwall, R; Saini, D; Sarin, SK; Sharma, MK; Vashishtha, C | 1 |
| Goyal, O; Puri, S; Sehgal, N; Sidhu, SS | 1 |
| Kim, SM; Song, IH | 1 |
| Fallowfield, JA; Gifford, FJ; Morling, JR | 1 |
| Cho, DH; Ha, JS; Oh, JE; Shim, SG; Yu, GJ | 1 |
| Kalambokis, GN; Tsianos, EV | 1 |
| Döhler, KD; Meyer, M | 1 |
| Ahn, SH; Baik, SK; Cho, M; Cho, SH; Choi, SK; Hahn, T; Han, KH; Heo, J; Kim, BI; Kim, JH; Kim, YH; Lee, HW; Park, SH; Seo, YS; Um, SH; Yoo, TW; Yu, SK | 1 |
| Bendtsen, F; Borup, T; Krag, A; Møller, S | 1 |
| Denzer, UW; Geibler, M; Glowa, F; Lohse, AW; von Kalckreuth, V | 1 |
| Abbas, Z; Abid, S; Azam, Z; Hamid, S; Jafri, W; Mumtaz, K; Salih, M; Shah, HA | 1 |
| Chan, HH; Chen, WC; Cheng, LC; Lin, CK; Lo, GH; Tsai, WL; Tsay, FW; Wang, HM; Yu, HC | 1 |
| Cazzaniga, M; Salerno, F | 1 |
| Atsukawa, M; Fukuda, T; Harimoto, H; Kanazawa, H; Katakura, T; Kidokoro, H; Kimura, Y; Matsushita, Y; Nakatsuka, K; Narahara, Y; Sakamoto, C; Taki, Y | 1 |
| Schepke, M | 1 |
| Arroyo, V; Baccaro, ME; Ginès, P; Guevara, M; Marinelli, M; Martín-Llahi, M; Nazar, A; Pepin, MN; Pereira, GH; Solá, E; Terra, C | 1 |
| Burroughs, AK; Cholongitas, E; Leandro, G; Marelli, L; Patch, D; Samonakis, D; Senzolo, M; Thalheimer, U; Triantos, CK | 1 |
| Asfar, P; Calès, P; Oberti, F; Radermacher, P | 1 |
| Angus, PW; Testro, AG | 1 |
| D'Amico, G; Pagliaro, L; Pietrosi, G; Tarantino, I | 2 |
| Demirjian, S; Dobre, M; Navaneethan, SD; Sehgal, AR | 1 |
| Bendtsen, F; Henriksen, JH; Krag, A; Mortensen, C; Møller, S | 1 |
| Abou Abbass, A; Fleming, JN | 1 |
| Baltayiannis, G; Kalambokis, GN; Katsanou, A; Pappas, K; Tsianos, EV | 1 |
| Baltayiannis, G; Fotopoulos, A; Kalambokis, G; Pakou, B; Tsianos, EV; Tsiouris, S | 1 |
| Kim, JW | 1 |
| Arroyo, V; Bosch, J; Escorsell, A; Fagundes, C; Fernández, J; Ginès, P; González-Abraldes, J; Guevara, M; Lens, S; Martín-Llahí, M; Mas, A; Pavesi, M; Pereira, G; Solà, E | 1 |
| Bruns, T; Fritzenwanger, M; Herrmann, A; Lehmann, M; Stallmach, A | 1 |
| Bendtsen, F; Krag, A; Møller, S; Pedersen, EB | 1 |
| Bastagli, L; Bernardi, M; Borghi, C; Buccione, D; Degli Esposti, D; Di Micoli, A; Santi, V; Trevisani, F | 1 |
| Biecker, E | 1 |
| Kalambokis, GN; Mouzaki, A; Pappas, K; Rodi, M; Tsianos, EV | 1 |
| Fukui, H; Kanazawa, H; Kokubu, S; Maruyama, H; Masaki, N; Matsuzaki, Y; Mochida, S; Narahara, Y; Okita, K; Sakamoto, C; Sumino, Y; Uemura, M; Yokosuka, O | 1 |
| Alexander, GJ; Srivastava, B | 1 |
| Cioffi, O; D'Adamo, G; Fimiani, B; Guardia, DD; Izzi, A; Pagano, A; Puoti, C; Tagliamonte, MR | 1 |
| Aagaard, NK; Bendtsen, F; Grønbaek, H; Hansen, JB; Møller, S; Schmidt, L | 1 |
| Andrade, L; Cerqueira, RM; Correia, MR; Fernandes, CD; Manso, MC | 1 |
| Fagundes, C; Ginès, P | 1 |
| Kalambokis, GN; Pappas, K; Tsianos, EV | 1 |
| Davenport, A | 1 |
| Bláha, V; Hrabovský, V; Hyšpler, R; Mendlová, A; Svagera, Z; Tichá, A; Zadák, Z | 1 |
| Bai, CX; He, BM; Huang, YY; Sun, JY; Wang, JY | 1 |
| Moreau, R | 1 |
| Barrière, E; Bernuau, J; Colle, I; Durand, F; Lebrec, D; Moreau, R; Pessione, F; Rassiat, E; Valla, DC | 1 |
| Arroyo, V; Bataller, R; Calahorra, B; Cárdenas, A; De Las Heras, D; Ginès, P; Guevara, M; Jiménez, W; Ortega, R; Rodés, J; Uriz, J | 1 |
| Singh Ranger, G | 1 |
| Alessandria, C; Barletti, C; Fadda, M; Marzano, A; Rizzetto, M; Venon, WD | 1 |
| Baik, SK; Choi, YJ; Jeong, PH; Kim, HS; Kim, MY; Kim, ND; Kim, YJ; Kwon, SO; Lee, DK; Park, DH; Park, JW | 1 |
| Baik, SK; Choi, YJ; Kim, HS; Kim, MY; Kim, YJ; Kwon, SO; Lee, DK; Park, DH; Park, JW | 1 |
| De Santis, A; Giorgi, A; Laviano, A; Riggio, O; Rossi-Fanelli, F; Vaccaro, F | 1 |
| Hayes, PC; Stanley, AJ; Therapondos, G | 1 |
| Abraldes, JG; Bosch, J; Dell'Era, A | 1 |
| Akkus, N; Altintas, E; Gen, R; Helvaci, MR; Oguz, D; Sezgin, O | 1 |
| Bihari, D; Boyle, M; Kurtovic, J; Riordan, SM | 1 |
| Aracil, C; Balanzó, J; González, B; López-Balaguer, JM; Miñana, J; Planella, M; Villanueva, C | 1 |
| Baik, SK; Chang, SJ; Jeong, PH; Ji, SW; Kim, HS; Kim, YJ; Kwon, SO; Lee, DK; Lee, SS; Park, JW; Yoo, BS | 1 |
| Chang, FY; Hou, MC; Huang, YT; Lee, FY; Lee, SD; Lin, HC; Yang, YY | 1 |
| Economou, M; Kalambokis, G; Katsaraki, A; Konstantinos, P; Pappas, C; Paraskevi, K; Tsianos, EV | 1 |
| Elisaf, M; Kalambokis, G; Milionis, H; Tsianos, EV | 1 |
| Angeli, P; Antona, C; Brollo, L; Cillo, U; Craighero, R; Fasolato, S; Franchin, M; Gatta, A; Guarda, S; Merkel, C; Miola, E; Piccolo, F | 1 |
| Kumar, R; Nain, CK; Sharma, AK; Singh, B; Singh, V | 1 |
| Lebrec, D; Moreau, R | 1 |
| Calès, P; Dib, N; Oberti, F | 1 |
| Akyuz, F; Besisik, F; Cakaloglu, Y; Ibrisim, D; Karadag, A; Mungan, Z; Okten, A; Ozdil, S | 1 |
| Baik, SK; Chang, SJ; Han, KH; Kim, HS; Kim, JW; Kim, SH; Kim, YJ; Kwon, SO; Lee, DK; Lee, SS; Park, JW; Um, SH | 1 |
| Choi, JH; Chun, HJ; Hyun, JJ; Jeen, YT; Keum, BR; Kim, CD; Kim, YH; Kim, YS; Lee, HS; Lee, SW; Park, S; Ryu, HS; Seo, YS; Um, SH | 1 |
| Cho, SB; Choi, SK; Joo, YE; Kim, HS; Kim, SJ; Lee, JS; Lee, WS; Park, CH; Park, KJ; Rew, JS | 1 |
| Gerbes, AL; Gülberg, V | 1 |
| Badruddin, AH; Chaudhry, MA; Rasool, G | 1 |
| Arroyo, V; Gerbes, A; Ginès, P; Salerno, F; Wong, F | 1 |
| Altorjay, I; Papp, M; Tornai, I; Udvardy, M; Vitális, Z | 1 |
| Bhatt, A; Burroughs, A; Connolly, M; Currie, CJ; McEwan, P; Tetlow, A; Wechowski, J; Woehl, A | 1 |
| Zuberi, BF | 1 |
| Cullen, G; Donnellan, F; Hegarty, JE; McCormick, PA | 1 |
| Bertino, G; Castellino, P; Cosimo, BM; Ignaccolo, L; Malaguarnera, M; Neri, S; Pulvirenti, D; Siringo, S | 1 |
| Bernardi, M; Bracci, E; Cappa, FM; Casadio, R; Di Micoli, A; Fontana, K; Trevisani, F; Zambruni, A | 1 |
| de Franchis, R; Dell'Era, A; Iannuzzi, F | 1 |
| Arroyo, V; Díaz, F; Fábrega, E; Ginès, P; Guevara, M; Martín-Llahí, M; Monescillo, A; Pépin, MN; Rodés, J; Soriano, G; Terra, C; Torre, A | 1 |
| Aprea, G; Casucci, R; Masciariello, S; Santini, M; Sodo, M | 1 |
| Douglas, JG; Forrest, JA; Forsling, ML; Prowse, CV | 1 |
| Bretagne, JF; Gosselin, M; Heresbach, D | 1 |
| Groszmann, RJ; Lopez-Talavera, JC | 1 |
| Blaise, M; Lapandry, C; Letoumelin, P; Levacher, S; Pateron, D; Pourriat, JL | 1 |
| Calzetti, C; Elia, G; Fiaccadori, F; Magnani, G; Pedretti, G | 1 |
| D'Amico, G; Luca, A; Montalbano, L; Morabito, A; Pagliaro, L; Pasta, L; Politi, F; Tinè, F; Traina, M; Vizzini, G | 1 |
| Andreoni, B; Arcidiacono, PG; Battaglia, G; Brunati, S; Carpinelli, L; Cestari, L; de Franchis, R; Mannucci, PM; Zambelli, A | 1 |
| Bordas, JM; Bosch, J; Llach, J; Panés, J; Piqué, JM; Rodés, J; Terés, J | 1 |
| Boyer, J; Carpentier, S; Czernichow, B; Doffël, M; Fort, E; Ingrand, P; Métreau, JM; Pillegand, B; Sautereau, D; Silvain, C | 1 |
| Cailmail, S; Gadano, A; Hadengue, A; Lebrec, D; Moreau, R; Sogni, P; Soupison, T; Vachiery, F; Yang, S | 1 |
| Bode, JC; Kreichgauer, HP; Walker, S | 1 |
| Nevens, F | 1 |
| Bandi, JC; Bosch, J; Escorsell, A; Feu, F; García-Pagan, JC; Moitinho, E; Rodés, J | 1 |
| Blanc, P; Bories, JM; David, XR; Desprez, D; García-Compeán, D; Larrey, D; Michel, H; Michel, J; Pageaux, GP | 1 |
| Durand, F; Erlinger, S; Gadano, A; Giostra, E; Hadengue, A; Lebrec, D; Moreau, R; Valla, D | 1 |
| de Franchis, R | 1 |
| Combier, E; de Pouvourville, G; Joseph, A; Letoumelin, P; Levacher, S; Pourriat, JL | 1 |
| Argonz, J; Bildozola, M; Kravetz, D; Romero, G; Suarez, A; Terg, R | 1 |
| Burroughs, A; Dagher, L; Marley, R; Moore, K; Patch, D | 1 |
| Albillos, A; Bañares, R; Bernard, B; Bosch, J; Calès, P; Escorsell, A; Pateron, D; Planas, R; Ruiz del Arbol, L; Vinel, JP | 1 |
| Jalan, R; Kapoor, D | 1 |
| Chang, FY; Hou, MC; Lee, FY; Lee, SD; Lee, WC; Lin, HC; Yang, YY | 1 |
| Lebrec, D | 1 |
| Asselah, T; Bernard, B; Binn, M; Condat, B; de Kerguenec, C; Grangé, JD; Lebrec, D; Moreau, R; Pessione, F; Poynard, T; Valla, D | 1 |
| Abergel, A; Bernard, B; Blanc, P; Bronowicki, JP; Butel, J; Cadranel, JF; Cervoni, JP; Coumaros, D; Ducloux, S; Duhamel, C; Durand, F; Fleurot, C; Giostra, E; Gurnot, D; Hadengue, A; Halimi, C; Ichaï, P; Lebrec, D; Levy, S; Moreau, R; Nouel, O; Pariente, A; Pauwels, M; Perarnau, JM; Platek, A; Poynard, T; Renard, P; Rivoal, M; Roche, J; Samuel, D; Scribe-Outtas, M; Valla, D | 1 |
| Bernard, B; Bonnard, P; Cadranel, JF; Demontis, R; di Martino, V; Fievet, P; Halimi, C; Henry-Biabaud, E; Mathurin, P; Mofredj, A; Opolon, P; Poynard, T | 1 |
| Chang, FY; Hou, MC; Huang, YT; Lee, FY; Lee, SD; Lee, WC; Lin, HC; Yang, YY | 1 |
| Arroyo, V | 1 |
| Calahorra, B; Ginès, P; Ortega, R | 1 |
| Amodio, P; Bianco, S; Bolognesi, M; Caregaro, L; Gatta, A; Merkel, C; Sacerdoti, D | 1 |
| Chang, TT; Lay, CS; Lee, FY; Lee, SD; Lin, HC; Lo, KJ; Tsai, YT; Wang, SS | 2 |
| Braga, M; Burroughs, AK; Cestari, R; Missale, G; Ravelli, P | 1 |
| Fort, E | 1 |
| Cervinka, J; Jedlicka, J; Kaláb, M; Kordac, V; Marecek, Z; Petrtýl, J; Srnský, J; Vrána, J | 1 |
| Gerunda, GE; Maffei Faccioli, A; Monti, G | 1 |
| Meyer zum Büschenfelde, KH; Rambow, A; Staritz, M | 1 |
| Hadengue, A; Lebrec, D; Lee, SS; Moreau, R; Sayegh, R; Valla, D | 1 |
52 review(s) available for terlipressin and Liver Cirrhosis
| Article | Year |
|---|---|
Hepatorenal Syndrome Type 1: From Diagnosis Ascertainment to Goal-Oriented Pharmacologic Therapy.
Topics: Acute Kidney Injury; Goals; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Terlipressin | 2022 |
AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients With Cirrhosis: Expert Review.
Topics: Acute Kidney Injury; Albumins; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Creatinine; Diuretics; Humans; Liver Cirrhosis; Midodrine; Necrosis; Norepinephrine; Octreotide; Terlipressin | 2022 |
Diagnosis and Management of Cirrhosis and Its Complications: A Review.
Topics: Adult; Ascites; Carvedilol; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Hepatorenal Syndrome; Humans; Lactulose; Liver Cirrhosis; Liver Neoplasms; Male; Muscle Cramp; Propranolol; Randomized Controlled Trials as Topic; Sodium Potassium Chloride Symporter Inhibitors; Terlipressin; United States | 2023 |
Hepatorenal Syndrome: Pathophysiology, Diagnosis, and Treatment.
Topics: Acute Kidney Injury; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Liver Transplantation; Terlipressin; Vasoconstrictor Agents | 2023 |
Peptide-based therapy in portal hypertension.
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Octreotide; Peptide Fragments; Somatostatin; Terlipressin | 2020 |
[Research progress of terlipressin in the treatment of cirrhotic ascites-related complications].
Topics: Antihypertensive Agents; Ascites; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2019 |
Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence.
Topics: Arterial Pressure; Ascites; Clinical Trials as Topic; Glomerular Filtration Rate; Hemodynamics; Humans; Kidney; Liver Cirrhosis; Paracentesis; Postoperative Complications; Renal Circulation; Terlipressin; Treatment Outcome; Vascular Diseases; Vascular Resistance; Vasoconstrictor Agents | 2020 |
Terlipressin has stood the test of time: Clinical overview in 2020 and future perspectives.
Topics: Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Terlipressin; Vasoconstrictor Agents | 2020 |
Vasoactive Agents for the Management of Acute Variceal Bleeding: A Systematic Review and Meta-analysis.
Topics: Adult; Aged; Blood Transfusion; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Length of Stay; Liver Cirrhosis; Male; Middle Aged; Octreotide; Recurrence; Somatostatin; Terlipressin; Treatment Outcome; Vasopressins | 2021 |
Renal dysfunctions and liver disease: a brief update on management with particular attention to hepatorenal syndrome.
Topics: Hepatorenal Syndrome; Humans; Liver Cirrhosis; Liver Transplantation; Terlipressin; Vasoconstrictor Agents | 2023 |
The Current Management of Hepatorenal Syndrome-Acute Kidney Injury in the United States and the Potential of Terlipressin.
Topics: Acute Kidney Injury; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Liver Transplantation; Terlipressin; United States; Vasoconstrictor Agents | 2021 |
Advances in management of hepatorenal syndrome.
Topics: Acute Kidney Injury; End Stage Liver Disease; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Terlipressin | 2021 |
Acute variceal bleeding: risk stratification and management (including TIPS).
Topics: Acute Disease; Combined Modality Therapy; Endoscopy, Digestive System; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Ligation; Liver Cirrhosis; Lypressin; Portasystemic Shunt, Transjugular Intrahepatic; Risk Assessment; Terlipressin; Vasoconstrictor Agents | 2018 |
Management of ascites and hepatorenal syndrome.
Topics: Acute Kidney Injury; Albumins; Ascites; Bacterial Translocation; Diet, Sodium-Restricted; Diuretics; Hemodynamics; Hepatorenal Syndrome; Humans; Hypertension, Portal; Hyponatremia; Liver Cirrhosis; Liver Transplantation; Lypressin; Paracentesis; Peritonitis; Portasystemic Shunt, Transjugular Intrahepatic; Splanchnic Circulation; Terlipressin; Vasoconstrictor Agents; Vasodilation | 2018 |
Terlipressin: Current and emerging indications in chronic liver disease.
Topics: Chronic Disease; Humans; Infusions, Intravenous; Liver Circulation; Liver Cirrhosis; Liver Diseases; Lypressin; Portal Pressure; Renal Circulation; Terlipressin | 2018 |
Hepatorenal syndrome.
Topics: Acute Kidney Injury; Bacterial Infections; Biomarkers; Creatinine; Fatty Acid-Binding Proteins; Hepatitis A Virus Cellular Receptor 1; Hepatorenal Syndrome; Humans; Inflammation; Interleukin-18; Lipocalin-2; Liver Cirrhosis; Risk Factors; Serum Albumin; Terlipressin; Vasoconstrictor Agents | 2018 |
Terlipressin for the treatment of acute variceal bleeding: A systematic review and meta-analysis of randomized controlled trials.
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Randomized Controlled Trials as Topic; Sclerotherapy; Terlipressin; Vasoconstrictor Agents | 2018 |
Management of ascites in patients with liver cirrhosis: recent evidence and controversies.
Topics: Ascites; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Midodrine; Portasystemic Shunt, Transjugular Intrahepatic; Propranolol; Terlipressin | 2013 |
[Hepatorenal syndrome: diagnosis, treatment and prevention].
Topics: Albumins; Ascites; Drug Therapy, Combination; Evidence-Based Medicine; Hepatorenal Syndrome; Humans; Kidney; Liver Cirrhosis; Liver Transplantation; Lypressin; Portasystemic Shunt, Transjugular Intrahepatic; Terlipressin; Vasoconstrictor Agents | 2013 |
Ischemic skin necrosis following terlipressin therapy: report of two cases and review of the literature.
Topics: Aged; Hepatorenal Syndrome; Humans; Ischemia; Liver Cirrhosis; Lypressin; Male; Necrosis; Skin Diseases; Terlipressin; Vasoconstrictor Agents | 2012 |
[Bleeding from the esophageal and gastric varices in patients with liver cirrhosis].
Topics: Esophageal and Gastric Varices; Esophagus; Gastrointestinal Hemorrhage; Hemostasis, Surgical; Humans; Liver Cirrhosis; Lypressin; Outcome Assessment, Health Care; Patient Selection; Portacaval Shunt, Surgical; Portal System; Prognosis; Stomach; Terlipressin; Vasoconstrictor Agents | 2013 |
[The modern possibilities of the hepato-renal syndrome treatment].
Topics: Comparative Effectiveness Research; Hemodynamics; Hepatorenal Syndrome; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Nitric Oxide; Outcome Assessment, Health Care; Portasystemic Shunt, Transjugular Intrahepatic; Randomized Controlled Trials as Topic; Renal Replacement Therapy; Terlipressin; Vasoconstrictor Agents | 2013 |
Acute kidney injury and hepatorenal syndrome in cirrhosis.
Topics: Acute Kidney Injury; Albumins; Ascites; Disease Progression; Drug Therapy, Combination; Early Diagnosis; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Liver Transplantation; Lypressin; Portasystemic Shunt, Transjugular Intrahepatic; Terlipressin | 2015 |
The Treatment of Hepatorenal Syndrome.
Topics: Adrenergic alpha-Antagonists; Albumins; Antihypertensive Agents; Drug Therapy, Combination; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Terlipressin | 2015 |
Diagnosing and treating renal disease in cirrhotic patients.
Topics: Creatinine; Glomerular Filtration Rate; Humans; Kidney Diseases; Liver Cirrhosis; Liver Transplantation; Lypressin; Midodrine; Norepinephrine; Portasystemic Shunt, Surgical; Renal Replacement Therapy; Terlipressin; Vasoconstrictor Agents | 2016 |
[Hepatorenal syndrome in decompensated cirrhosis : A special form of acute renal failure].
Topics: Critical Care; Fluid Therapy; Hepatorenal Syndrome; Humans; Kidney Function Tests; Liver Cirrhosis; Liver Failure; Liver Transplantation; Lypressin; Prognosis; Serum Albumin; Terlipressin; Vasoconstrictor Agents | 2016 |
Emerging hepatic syndromes: pathophysiology, diagnosis and treatment.
Topics: Acute Kidney Injury; Adrenal Insufficiency; Ascites; Creatinine; Evidence-Based Medicine; Hepatorenal Syndrome; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Transplantation; Lypressin; Midodrine; Norepinephrine; Octreotide; Plasma Substitutes; Portasystemic Shunt, Transjugular Intrahepatic; Serum Albumin; Terlipressin; Vasodilator Agents; Vasopressins | 2016 |
[Acute Kidney Injury in Cirrhotic Patients with Portal Hypertension].
Topics: Acute Kidney Injury; Biomarkers; Creatinine; Humans; Hypertension, Portal; Kidney Transplantation; Liver Cirrhosis; Lypressin; Serum Albumin; Terlipressin | 2016 |
Systematic review with meta-analysis: vasoactive drugs for the treatment of hepatorenal syndrome type 1.
Topics: Albumins; Creatinine; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Prognosis; Randomized Controlled Trials as Topic; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2017 |
Vasopressin analogues in the treatment of hepatorenal syndrome and gastrointestinal haemorrhage.
Topics: Animals; Blood Circulation; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Humans; Hypovolemia; Liver Cirrhosis; Lypressin; Splanchnic Circulation; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2008 |
Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome.
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemodynamics; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Liver Failure, Acute; Lypressin; Midodrine; Norepinephrine; Octreotide; Paracentesis; Randomized Controlled Trials as Topic; Somatostatin; Terlipressin; Vasoconstrictor Agents | 2008 |
[Importance of drug treatment to lower portal pressure in the therapy of variceal bleeding].
Topics: Adrenergic beta-Antagonists; Anti-Bacterial Agents; Drug Therapy, Combination; Esophageal and Gastric Varices; Esophagoscopy; Gastrointestinal Hemorrhage; Hormones; Humans; Hypertension, Portal; Infection Control; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Lypressin; Portal Pressure; Secondary Prevention; Somatostatin; Terlipressin; Vasoconstrictor Agents; Vasodilator Agents | 2009 |
The effects of vasopressin and its analogues on the liver and its disorders in the critically ill.
Topics: Critical Care; Critical Illness; Hemodynamics; Hepatorenal Syndrome; Humans; Intensive Care Units; Liver; Liver Cirrhosis; Lypressin; Risk Factors; Shock, Septic; Terlipressin; Varicose Veins; Vasoconstrictor Agents; Vasopressins | 2010 |
Emergency sclerotherapy versus vasoactive drugs for bleeding oesophageal varices in cirrhotic patients.
Topics: Emergencies; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemostatics; Humans; Liver Cirrhosis; Lypressin; Octreotide; Sclerotherapy; Somatostatin; Terlipressin; Treatment Outcome; Vasoconstrictor Agents; Vasopressins | 2010 |
Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis.
Topics: Antihypertensive Agents; Diagnosis, Differential; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Terlipressin; Treatment Outcome | 2011 |
Hepatorenal syndrome: a comprehensive overview for the critical care nurse.
Topics: Critical Care; Disease Progression; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Liver Transplantation; Lypressin; Portasystemic Shunt, Transjugular Intrahepatic; Risk Factors; Terlipressin; Vasoconstrictor Agents; Vasodilation | 2010 |
Renal failure in chronic liver disease and the hepatorenal syndrome.
Topics: Bilirubin; Chronic Disease; Evidence-Based Practice; Fluid Therapy; Hemodynamics; Hepatorenal Syndrome; Humans; Kidney; Liver; Liver Cirrhosis; Liver Transplantation; Lypressin; Monitoring, Physiologic; Patient Selection; Portasystemic Shunt, Surgical; Regional Blood Flow; Renal Insufficiency; Serum Albumin; Severity of Illness Index; Terlipressin; Vasoconstrictor Agents | 2011 |
Recent advances in our understanding of hepatorenal syndrome.
Topics: Comorbidity; Hemodynamics; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Liver Transplantation; Lypressin; Norepinephrine; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2012 |
Hepatorenal syndrome in patients with cirrhosis.
Topics: Hepatorenal Syndrome; Humans; Liver Cirrhosis; Liver Transplantation; Lypressin; Primary Prevention; Prognosis; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2002 |
Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis.
Topics: Acute Disease; Emergency Medical Services; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemostatics; Hormones; Humans; Liver Cirrhosis; Lypressin; Octreotide; Randomized Controlled Trials as Topic; Sclerotherapy; Somatostatin; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2003 |
Medical management of variceal bleeding in patients with cirrhosis.
Topics: Algorithms; Combined Modality Therapy; Esophageal and Gastric Varices; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hemostatics; Humans; Liver Cirrhosis; Lypressin; Octreotide; Practice Guidelines as Topic; Somatostatin; Terlipressin; Vasoconstrictor Agents | 2004 |
The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond.
Topics: Adrenergic alpha-Agonists; Cardiovascular Diseases; Drug Therapy, Combination; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Paracentesis; Shock, Septic; Splanchnic Circulation; Terlipressin; Vasoconstrictor Agents; Vasodilation | 2006 |
Current management of the complications of portal hypertension: variceal bleeding and ascites.
Topics: Algorithms; Anti-Bacterial Agents; Ascites; Collateral Circulation; Diuretics; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Hormones; Hypertension, Portal; Liver Cirrhosis; Lypressin; Peritonitis; Portasystemic Shunt, Transjugular Intrahepatic; Sclerotherapy; Secondary Prevention; Somatostatin; Spironolactone; Terlipressin; Vascular Resistance; Vasoconstrictor Agents; Vasodilation; Vasopressins | 2006 |
[Renal impairment in liver diseases].
Topics: Diagnosis, Differential; Hepatorenal Syndrome; Humans; Kidney Transplantation; Liver Cirrhosis; Lypressin; Portasystemic Shunt, Transjugular Intrahepatic; Prognosis; Renal Insufficiency; Serum Albumin; Terlipressin | 2006 |
Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.
Topics: Albumins; Hepatorenal Syndrome; Humans; Infusions, Parenteral; Liver Cirrhosis; Liver Transplantation; Lypressin; Portasystemic Shunt, Transjugular Intrahepatic; Renal Dialysis; Terlipressin; Vasoconstrictor Agents | 2007 |
[Gastroesophageal variceal haemorrhage--new advances in pathophysiology].
Topics: Antihypertensive Agents; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Lypressin; Risk Factors; Rupture, Spontaneous; Terlipressin; Vasoconstrictor Agents | 2006 |
Acute variceal bleeding: pharmacological treatment and primary/secondary prophylaxis.
Topics: Acute Disease; Adrenergic beta-Antagonists; Antibiotic Prophylaxis; Drug Therapy, Combination; Esophageal and Gastric Varices; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Octreotide; Somatostatin; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2008 |
[Emergency medical treatment of portal hypertension].
Topics: Combined Modality Therapy; Emergency Medicine; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Octreotide; Sclerotherapy; Somatostatin; Terlipressin | 1995 |
Longer treatment with vasoactive drugs to prevent early variceal rebleeding in cirrhosis.
Topics: Acute Disease; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemostatics; Humans; Liver Cirrhosis; Lypressin; Recurrence; Terlipressin | 1998 |
Review article: pharmacological treatment of the hepatorenal syndrome in cirrhotic patients.
Topics: Disease Progression; Felypressin; Hepatitis, Alcoholic; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Liver Transplantation; Lypressin; Octreotide; Renal Agents; Terlipressin; Vasoconstrictor Agents | 2000 |
[Physiopathology of refractory ascites and the hepatorenal syndrome].
Topics: Ascites; Glomerular Filtration Rate; Hepatorenal Syndrome; Humans; Hypertension, Portal; Hypotension; Kidney; Liver Cirrhosis; Lypressin; Ornipressin; Paracentesis; Peritoneovenous Shunt; Peritonitis; Plasma Substitutes; Renin-Angiotensin System; Splanchnic Circulation; Sympathetic Nervous System; Tachycardia; Terlipressin; Vasoconstriction | 2002 |
[Vasoconstrictors in the treatment of hepatorenal syndrome].
Topics: Adrenergic alpha-Agonists; Albumins; Drug Evaluation; Drug Therapy, Combination; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Midodrine; Octreotide; Ornipressin; Pilot Projects; Renal Circulation; Terlipressin; Vasoconstrictor Agents | 2002 |
54 trial(s) available for terlipressin and Liver Cirrhosis
| Article | Year |
|---|---|
Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure.
Topics: Acute-On-Chronic Liver Failure; Albumins; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Respiratory Insufficiency; Terlipressin; Vasoconstrictor Agents | 2022 |
Low-dose continuous terlipressin infusion is effective and safer than intravenous bolus injections in reducing portal pressure and control of acute variceal bleeding.
Topics: End Stage Liver Disease; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Lypressin; Portal Pressure; Severity of Illness Index; Terlipressin | 2023 |
Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial.
Topics: Acute Kidney Injury; Albumins; Ascites; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Portasystemic Shunt, Transjugular Intrahepatic; Prospective Studies; Quality of Life; Terlipressin | 2023 |
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.
Topics: Albumins; Combined Modality Therapy; Double-Blind Method; Female; Hepatorenal Syndrome; Humans; Infusions, Intravenous; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Renal Replacement Therapy; Respiratory Insufficiency; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2021 |
Comparison of 12-Hour with 72-Hour Terlipressin Therapy for Bleeding Esophageal Varices.
Topics: Adult; Aged; Combined Modality Therapy; Drug Administration Schedule; Endoscopy; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Ligation; Liver Cirrhosis; Lypressin; Male; Middle Aged; Terlipressin; Time Factors; Treatment Outcome; Vasoconstrictor Agents | 2017 |
Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial.
Topics: Adult; Ascites; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Ligation; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Octreotide; Portasystemic Shunt, Transjugular Intrahepatic; Recurrence; Somatostatin; Stents; Survival Rate; Terlipressin; Time Factors; Treatment Outcome; Vasoconstrictor Agents | 2019 |
[A comparative study of high-or low-dose terlipressin therapy in patients with cirrhosis and type 1 hepatorenal syndrome].
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Female; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Retrospective Studies; Terlipressin; Treatment Outcome; Young Adult | 2014 |
[Response to Terlipressin and albumin is associated with improved outcome in patients with cirrhosis and hepatorenal syndrome].
Topics: Adult; Aged; Albumins; Antihypertensive Agents; Drug Therapy, Combination; Female; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Terlipressin; Treatment Outcome | 2015 |
Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1.
Topics: Adult; Albumins; Canada; Drug Therapy, Combination; Female; Hepatorenal Syndrome; Humans; Kidney; Kidney Function Tests; Liver Cirrhosis; Lypressin; Male; Middle Aged; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2016 |
Effect of different therapeutic modalities on systemic, renal, and hepatic hemodynamics and short-term outcomes in cirrhotic patients with spontaneous bacterial peritonitis.
Topics: Adult; Bacterial Infections; Drug Therapy, Combination; Female; Hemodynamics; Hepatorenal Syndrome; Humans; Liver Circulation; Liver Cirrhosis; Lypressin; Male; Middle Aged; Midodrine; Peritonitis; Renal Circulation; Serum Albumin; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2016 |
A randomized trial comparing terlipressin and noradrenaline in patients with cirrhosis and septic shock.
Topics: Adult; Female; Hemodynamics; Humans; India; Kaplan-Meier Estimate; Lactic Acid; Liver Cirrhosis; Logistic Models; Lypressin; Male; Microcirculation; Middle Aged; Norepinephrine; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2017 |
Noradrenaline is as Effective as Terlipressin in Hepatorenal Syndrome Type 1: A Prospective, Randomized Trial.
Topics: Adrenergic alpha-Agonists; Creatinine; Female; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Norepinephrine; Prospective Studies; Terlipressin; Vasoconstrictor Agents | 2016 |
Terlipressin vs. octreotide in bleeding esophageal varices as an adjuvant therapy with endoscopic band ligation: a randomized double-blind placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Double-Blind Method; Esophageal and Gastric Varices; Female; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hemostasis, Endoscopic; Humans; Length of Stay; Ligation; Liver Cirrhosis; Lypressin; Male; Middle Aged; Octreotide; Terlipressin; Vasoconstrictor Agents; Young Adult | 2009 |
Low-dose terlipressin plus banding ligation versus low-dose terlipressin alone in the prevention of very early rebleeding of oesophageal varices.
Topics: Aged; Combined Modality Therapy; Drug Administration Schedule; Endoscopy; Esophageal and Gastric Varices; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Kaplan-Meier Estimate; Ligation; Liver Cirrhosis; Lypressin; Proportional Hazards Models; Recurrence; Survival Rate; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2009 |
Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
Topics: Aged; Blood Pressure; Cardiac Output; Female; Heart Rate; Hemodynamics; Hepatorenal Syndrome; Humans; Hypertension, Portal; Injections, Intravenous; Liver Circulation; Liver Cirrhosis; Lypressin; Male; Middle Aged; Neurotransmitter Agents; Placebo Effect; Renal Circulation; Terlipressin; Treatment Outcome; Ultrasonography, Doppler; Vascular Resistance; Vasoconstrictor Agents | 2009 |
Effects of a single terlipressin administration on cardiac function and perfusion in cirrhosis.
Topics: Aged; Ascites; Blood Pressure; Cardiac Output; Electrocardiography; Female; Heart Function Tests; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Stroke Volume; Terlipressin; Tomography, Emission-Computed, Single-Photon; Vasoconstrictor Agents; Ventricular Function, Left | 2010 |
Effects of terlipressin on water excretion after oral water load test in nonazotemic cirrhotic patients with ascites without hyponatremia.
Topics: Ascites; Diuresis; Drinking; Female; Humans; Hyponatremia; Liver Cirrhosis; Lypressin; Male; Middle Aged; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2010 |
Effects of terlipressin and somatostatin on liver and thorax blood volumes in patients with cirrhosis.
Topics: Esophageal and Gastric Varices; Female; Gamma Cameras; Hemodynamics; Hormones; Humans; Hypertension, Portal; Infusions, Intravenous; Liver Circulation; Liver Cirrhosis; Lypressin; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Somatostatin; Technetium Tc 99m Sestamibi; Terlipressin; Thorax; Vasoconstrictor Agents | 2010 |
Effects of the vasopressin agonist terlipressin on plasma cAMP and ENaC excretion in the urine in patients with cirrhosis and water retention.
Topics: Antihypertensive Agents; Cyclic AMP; Demography; Epithelial Sodium Channels; Female; Humans; Kidney; Liver Cirrhosis; Lypressin; Male; Middle Aged; Receptors, Vasopressin; Sodium; Terlipressin; Vasopressins; Water-Electrolyte Balance | 2011 |
The efficacy and safety of terlipressin and albumin in patients with type 1 hepatorenal syndrome: a multicenter, open-label, explorative study.
Topics: Aged; Albumins; Antihypertensive Agents; Creatinine; Drug Therapy, Combination; Female; Hepatorenal Syndrome; Humans; Japan; Liver Cirrhosis; Lypressin; Male; Middle Aged; Norepinephrine; Prospective Studies; Renin; Survival Rate; Terlipressin; Treatment Outcome | 2012 |
The use of terlipressin in cirrhotic patients with refractory ascites and normal renal function: a multicentric study.
Topics: Adult; Aged; Albumins; Ascites; Diuretics; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatorenal Syndrome; Humans; Kidney; Liver Cirrhosis; Lypressin; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2011 |
Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study.
Topics: Adult; Aged; Albumins; Antihypertensive Agents; Drug Therapy, Combination; Female; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Prospective Studies; Recurrence; Survival Analysis; Terlipressin | 2002 |
Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2.
Topics: Female; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Portasystemic Shunt, Surgical; Prospective Studies; Terlipressin; Treatment Outcome; Urination; Vasoconstrictor Agents | 2002 |
Effects of terlipressin on systolic pulmonary artery pressure of patients with liver cirrhosis: an echocardiographic assessment.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Echocardiography; Female; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Pulmonary Artery; Terlipressin | 2004 |
Hemodynamic effects of terlipressin and high somatostatin dose during acute variceal bleeding in nonresponders to the usual somatostatin dose.
Topics: Aged; Blood Pressure; Double-Blind Method; Esophageal and Gastric Varices; Female; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Liver Circulation; Liver Cirrhosis; Lypressin; Male; Middle Aged; Somatostatin; Terlipressin; Vasoconstrictor Agents; Venous Pressure | 2005 |
Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison.
Topics: Blood Pressure; Esophageal and Gastric Varices; Female; Gastrointestinal Agents; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Liver Circulation; Liver Cirrhosis; Lypressin; Male; Middle Aged; Octreotide; Portal System; Terlipressin; Ultrasonography, Doppler, Duplex; Vasoconstrictor Agents; Venous Pressure | 2005 |
Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis.
Topics: Antihypertensive Agents; Female; Hemodynamics; Hormones; Humans; Infusions, Intravenous; Injections, Intravenous; Liver Cirrhosis; Lypressin; Male; Middle Aged; Portal Vein; Sodium; Somatostatin; Terlipressin; Ultrasonography, Doppler, Color | 2005 |
Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost.
Topics: Administration, Oral; Albumins; Anti-Bacterial Agents; Antihypertensive Agents; Ceftazidime; Ciprofloxacin; Female; Health Care Costs; Hepatorenal Syndrome; Humans; Infusions, Intravenous; Length of Stay; Liver Cirrhosis; Lypressin; Male; Middle Aged; Peritonitis; Terlipressin | 2006 |
Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
Topics: Albumins; Aldosterone; Ascites; Blood Volume; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Paracentesis; Plasma Substitutes; Renin; Terlipressin; Vasoconstrictor Agents | 2006 |
[A prospective study comparing the efficacy of early administration of terlipressin and somatostatin for the control of acute variceal bleeding in patients with cirrhosis].
Topics: Acute Disease; Aged; Carcinoma, Hepatocellular; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemorrhage; Hemostasis, Endoscopic; Humans; Liver; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Lypressin; Male; Middle Aged; Multivariate Analysis; Somatostatin; Terlipressin; Varicose Veins; Vasoconstrictor Agents | 2006 |
[Comparison of terlipressin and octreotide with variceal ligation for controlling acute esophageal variceal bleeding--a randomized prospective study].
Topics: Acute Disease; Aged; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Octreotide; Terlipressin; Vasoconstrictor Agents | 2006 |
Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.
Topics: Adolescent; Adult; Aged; Albumins; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatorenal Syndrome; Humans; Injections, Intravenous; Kidney Function Tests; Liver Cirrhosis; Lypressin; Male; Middle Aged; Retrospective Studies; Shock, Septic; Survival Rate; Terlipressin; Time Factors; Treatment Outcome; United States; Vasoconstrictor Agents | 2008 |
Drug therapy for acute bleeding from portal hypertensive gastropathy.
Topics: Acute Disease; Double-Blind Method; Gastric Mucosa; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Perfusion; Stomach Diseases; Terlipressin; Vasoconstrictor Agents; Vasopressins | 1995 |
Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients.
Topics: Adult; Aged; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Humans; Injections, Intravenous; Liver Cirrhosis; Lypressin; Male; Middle Aged; Nitroglycerin; Prospective Studies; Survival Analysis; Terlipressin; Vasodilator Agents | 1995 |
Octreotide versus terlypressin in acute variceal hemorrhage in liver cirrhosis. Emergency control and prevention of early rebleeding.
Topics: Cost-Benefit Analysis; Diuretics; Endoscopy, Digestive System; Female; Hemorrhage; Humans; Liver Cirrhosis; Liver Function Tests; Lypressin; Male; Middle Aged; Octreotide; Single-Blind Method; Survival Analysis; Terlipressin | 1994 |
Terlipressin or vasopressin plus transdermal nitroglycerin in a treatment strategy for digestive bleeding in cirrhosis. A randomized clinical trial. Liver Study Group of V. Cervello Hospital.
Topics: Administration, Cutaneous; Adult; Aged; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Nitroglycerin; Terlipressin; Vasopressins | 1994 |
Randomized controlled trial of desmopressin plus terlipressin vs. terlipressin alone for the treatment of acute variceal hemorrhage in cirrhotic patients: a multicenter, double-blind study. New Italian Endoscopic Club.
Topics: Acute Disease; Deamino Arginine Vasopressin; Double-Blind Method; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Terlipressin; Treatment Failure | 1993 |
Reduction of gastric hyperemia by glypressin and vasopressin administration in cirrhotic patients with portal hypertensive gastropathy.
Topics: Double-Blind Method; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Hyperemia; Hypertension, Portal; Laser-Doppler Flowmetry; Liver Cirrhosis; Lypressin; Male; Middle Aged; Oxygen; Regional Blood Flow; Spectrophotometry; Stomach Diseases; Terlipressin; Vasopressins | 1994 |
Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: a multicenter randomized trial.
Topics: Administration, Cutaneous; Adult; Aged; Blood Pressure; Drug Therapy, Combination; Emergencies; Esophageal and Gastric Varices; Female; France; Gastrointestinal Hemorrhage; Hematocrit; Humans; Infusions, Intravenous; Liver Cirrhosis; Lypressin; Male; Middle Aged; Nitroglycerin; Octreotide; Recurrence; Terlipressin | 1993 |
Hemodynamic and metabolic effects of terlipressin in patients with cirrhosis receiving a nonselective beta-blocker.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Drug Synergism; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Oxygen Consumption; Portal Pressure; Splanchnic Circulation; Terlipressin | 1996 |
Terlipressin (glypressin) versus somatostatin in the treatment of bleeding esophageal varices--final report of a placebo-controlled, double-blind study.
Topics: Adult; Aged; Antihypertensive Agents; Balloon Occlusion; Catheterization; Combined Modality Therapy; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Infusions, Intravenous; Liver Cirrhosis; Lypressin; Male; Middle Aged; Recurrence; Somatostatin; Survival Rate; Terlipressin; Treatment Failure; Treatment Outcome | 1996 |
Non-invasive variceal pressure measurements: validation and clinical implications.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure Determination; Double-Blind Method; Esophageal and Gastric Varices; Esophagoscopy; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Male; Middle Aged; Propranolol; Reproducibility of Results; Spironolactone; Terlipressin; Venous Pressure | 1996 |
Time profile of the haemodynamic effects of terlipressin in portal hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Dose-Response Relationship, Drug; Double-Blind Method; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Hypertension, Portal; Infusions, Intravenous; Liver Cirrhosis; Lypressin; Male; Middle Aged; Recurrence; Splanchnic Circulation; Terlipressin | 1997 |
Treatment of active gastroesophageal variceal bleeding with terlipressin or hemostatic balloon in patients with cirrhosis. A randomized controlled trial.
Topics: Adult; Aged; Antihypertensive Agents; Catheterization; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemodynamics; Hemostatic Techniques; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Male; Middle Aged; Recurrence; Survival Rate; Terlipressin; Treatment Outcome | 1997 |
Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome.
Topics: Atrial Natriuretic Factor; Blood Pressure; Cross-Over Studies; Double-Blind Method; Female; Glomerular Filtration Rate; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Sodium; Terlipressin | 1998 |
Cost-effectiveness analysis of the terlipressin-glycerin trinitrate combination in the pre-hospital management of acute gastro-intestinal haemorrhage in cirrhotic patients.
Topics: Acute Disease; Antihypertensive Agents; Cost-Benefit Analysis; Double-Blind Method; Drug Therapy, Combination; Emergency Treatment; Esophageal and Gastric Varices; Female; France; Gastrointestinal Hemorrhage; Humans; Intensive Care Units; Length of Stay; Liver Cirrhosis; Lypressin; Male; Nitroglycerin; Rupture, Spontaneous; Terlipressin | 1999 |
Terlipressin is more effective in decreasing variceal pressure than portal pressure in cirrhotic patients.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Esophageal and Gastric Varices; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Portal System; Splanchnic Circulation; Terlipressin | 2000 |
Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST study.
Topics: Acute Disease; Aged; Female; Hemorrhage; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Sclerotherapy; Terlipressin; Treatment Failure; Varicose Veins; Vasoconstrictor Agents | 2000 |
Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis.
Topics: Antihypertensive Agents; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Male; Middle Aged; Prazosin; Terlipressin | 2001 |
Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study.
Topics: Albumins; Analysis of Variance; Blood Volume; Creatinine; Female; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Paracentesis; Pilot Projects; Renin; Sodium; Survival Analysis; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2002 |
Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis.
Topics: Aged; Cardiac Output; Drug Therapy, Combination; Female; Hemodynamics; Hepatitis B; Hepatitis C; Humans; Hypertension, Portal; Infusions, Intravenous; Injections, Intravenous; Liver Circulation; Liver Cirrhosis; Lypressin; Male; Middle Aged; Octreotide; Terlipressin; Vascular Resistance; Vasoconstrictor Agents; Venous Pressure | 2002 |
Effect of triglycyl-lysin-vasopressin on quantitative liver function tests in patients with cirrhosis.
Topics: Adult; Aged; Female; Galactose; Humans; Indocyanine Green; Liver Cirrhosis; Liver Function Tests; Lypressin; Male; Middle Aged; Terlipressin | 1992 |
Haemodynamic effect of triglycyl-lysine-vasopressin (glypressin) on intravascular oesophageal variceal pressure in patients with cirrhosis. A randomized placebo controlled trial.
Topics: Adult; Aged; Blood Pressure; Double-Blind Method; Esophageal and Gastric Varices; Female; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Randomized Controlled Trials as Topic; Terlipressin | 1990 |
[Haemodynamic effect of triglycyl-lysine vasopressin (glypressin) on intravascular oesophageal variceal pressure in patients with cirrhosis. A randomized placebo controlled trial].
Topics: Drug Evaluation; Esophageal and Gastric Varices; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Placebos; Terlipressin | 1990 |
89 other study(ies) available for terlipressin and Liver Cirrhosis
| Article | Year |
|---|---|
Terlipressin-induced skin necrosis.
Topics: Humans; Liver Cirrhosis; Necrosis; Skin Abnormalities; Terlipressin; Vasoconstrictor Agents | 2021 |
Duodenal Necrosis and Nonvariceal Digestive Bleeding After Terlipressin Administration for Treatment of Hepatorenal Syndrome: a Case Report of a Novel Side Effect of a Commonly Used Drug.
Topics: Creatinine; End Stage Liver Disease; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Humans; Ischemia; Liver Cirrhosis; Lypressin; Male; Middle Aged; Necrosis; Severity of Illness Index; Terlipressin; Vasoconstrictor Agents | 2022 |
Terlipressin: Leading the Water to the Thirsty.
Topics: Humans; Liver Cirrhosis; Terlipressin; Vasoconstrictor Agents | 2022 |
Diagnostic and prognostic performance of urinary neutrophil gelatinase-associated lipocalin in patients with cirrhosis and acute kidney injury.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Biomarkers; End Stage Liver Disease; Humans; Lipocalin-2; Lipocalins; Liver Cirrhosis; Prognosis; Proto-Oncogene Proteins; Severity of Illness Index; Terlipressin | 2023 |
[Practice guidance for the use of terlipressin for liver cirrhosis-related complications (2021)].
Topics: Electrolytes; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Terlipressin; Vasoconstrictor Agents | 2022 |
Practical Management of HRS-AKI in the Era of Terlipressin: What the Gastroenterologist Needs to Know.
Topics: Acute Kidney Injury; Gastroenterologists; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2023 |
Responsiveness to Vasoconstrictor Therapy in Hepatorenal Syndrome Type 1.
Topics: Hepatorenal Syndrome; Humans; Liver Cirrhosis; Terlipressin; Vasoconstrictor Agents | 2023 |
What is the role for terlipressin in hepatorenal syndrome?
Topics: Hepatorenal Syndrome; Humans; Liver Cirrhosis; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2023 |
Clinical characteristics and risk factors of severe hyponatremia in cirrhotic patients treated with terlipressin.
Topics: Adult; Aged; Creatinine; Dose-Response Relationship, Drug; Female; Gastrointestinal Hemorrhage; Humans; Hyponatremia; Liver Cirrhosis; Male; Middle Aged; Peptic Ulcer; Retrospective Studies; Risk Factors; Serum Albumin, Human; Sodium; Terlipressin; Vasoconstrictor Agents | 2020 |
[Clinical curative effect observation of therapy of terlipressin combined with albumin in acute kidney injury with liver cirrhosis].
Topics: Acute Kidney Injury; Albumins; Humans; Liver Cirrhosis; Terlipressin | 2019 |
Changes in the management of variceal gastrointestinal haemorrhage in our department
Topics: Aged; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Male; Middle Aged; Retrospective Studies; Terlipressin; Treatment Outcome; Varicose Veins; Vasoconstrictor Agents | 2020 |
A study on clinical outcomes of combination of terlipressin and albumin in Hepatorenal Syndrome.
Topics: Aged; Albumins; Drug Therapy, Combination; Female; Hepatorenal Syndrome; Humans; India; Kidney; Kidney Function Tests; Liver Cirrhosis; Male; Middle Aged; Prospective Studies; Quality of Life; Recurrence; Terlipressin; Tertiary Care Centers; Treatment Outcome; Vasoconstrictor Agents | 2020 |
Terlipressin May Decrease In-Hospital Mortality of Cirrhotic Patients with Acute Gastrointestinal Bleeding and Renal Dysfunction: A Retrospective Multicenter Observational Study.
Topics: Gastrointestinal Hemorrhage; Hospital Mortality; Humans; Liver Cirrhosis; Retrospective Studies; Terlipressin | 2020 |
Safety and efficacy of outpatient continuous terlipressin infusion for the treatment of portal hypertensive complications in cirrhosis.
Topics: Ascites; End Stage Liver Disease; Hepatorenal Syndrome; Humans; Hydrothorax; Liver Cirrhosis; Lypressin; Outpatients; Severity of Illness Index; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2022 |
Haemodynamic changes in cirrhosis following terlipressin and induction of sepsis-a preclinical study using caval subtraction phase-contrast and cardiac MRI.
Topics: Animals; Hemodynamics; Humans; Liver Cirrhosis; Magnetic Resonance Imaging; Rats; Rats, Sprague-Dawley; Sepsis; Terlipressin | 2021 |
Letter: HRS-AKI - a frequent misdiagnosis in the real-world setting?
Topics: Acute Kidney Injury; Diagnostic Errors; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Terlipressin | 2020 |
Ischemic skin necrosis secondary to the use of terlipressin.
Topics: Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Necrosis; Terlipressin; Vasoconstrictor Agents | 2021 |
Terlipressin and Intravenous Albumin in Advanced Cirrhosis - Friend and Foe.
Topics: Albumins; Humans; Liver Cirrhosis; Terlipressin | 2021 |
Treatment of Severe Acute on Chronic Liver Failure: Management of Organ Failures, Investigational Therapeutics, and the Role of Liver Transplantation.
Topics: Acute-On-Chronic Liver Failure; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Liver Transplantation; Prognosis; Terlipressin | 2021 |
End-stage liver disease: Management of hepatorenal syndrome.
Topics: Acute Kidney Injury; End Stage Liver Disease; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Terlipressin; Vasoconstrictor Agents | 2021 |
Perioperative use of terlipressin in adult liver transplant.
Topics: Adult; Humans; Liver Cirrhosis; Liver Transplantation; Living Donors; Lypressin; Terlipressin; Vasoconstrictor Agents | 2017 |
Systemic hemodynamic response to terlipressin predicts development of hepatorenal syndrome and survival in advanced cirrhosis.
Topics: Aged; Area Under Curve; Arterial Pressure; Ascites; Cardiac Output; Female; Hemodynamics; Hepatorenal Syndrome; Humans; Linear Models; Liver Cirrhosis; Logistic Models; Lypressin; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Proportional Hazards Models; Reproducibility of Results; Retrospective Studies; Risk Factors; ROC Curve; Terlipressin; Time Factors; Vascular Resistance; Vasoconstrictor Agents | 2018 |
A rare and threatening complication in a cirrhotic patient.
Topics: Aged; Antihypertensive Agents; Foot; Humans; Liver Cirrhosis; Male; Necrosis; Terlipressin | 2018 |
Acute kidney injury in acute-on-chronic liver failure is different from in decompensated cirrhosis.
Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Adult; Biomarkers; Disease Progression; Female; Hepatitis B virus; Humans; Kidney Tubules; Liver Cirrhosis; Lypressin; Male; Middle Aged; Prospective Studies; Risk Factors; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2018 |
[An evidence-based terlipressin therapy for gastroesophageal variceal hemorrhage].
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Terlipressin; Treatment Outcome; Varicose Veins; Vasoconstrictor Agents | 2018 |
Characterization of inflammatory response in hepatorenal syndrome: Relationship with kidney outcome and survival.
Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Aged; Albumins; Biomarkers; Cytokines; Female; Hepatorenal Syndrome; Humans; Inflammation; Kidney; Liver; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Spain; Survival Analysis; Terlipressin; Vasoconstrictor Agents | 2019 |
Terlipressin-Induced Peripheral Cyanosis in a Patient with Liver Cirrhosis and Hepatorenal Syndrome.
Topics: Aged; Cyanosis; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Male; Terlipressin; Vasoconstrictor Agents | 2019 |
Terlipressin and albumin combination treatment in patients with hepatorenal syndrome type 2.
Topics: Aged; Albumins; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatorenal Syndrome; Humans; Kaplan-Meier Estimate; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Recurrence; Remission Induction; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2019 |
Estimating effect of terlipressin on portal pressure in cirrhosis by observing hepatic vein Doppler waveform.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure Determination; Female; Hepatic Veins; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Male; Middle Aged; Terlipressin; Ultrasonography, Doppler | 2013 |
A case of peripheral gangrene and osteomyelitis secondary to terlipressin therapy in advanced liver disease.
Topics: Aged; Creatinine; Foot; Gangrene; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Diseases; Lypressin; Male; Osteomyelitis; Radiography; Severity of Illness Index; Terlipressin; Toe Phalanges; Vasoconstrictor Agents | 2013 |
Upper gastrointestinal bleeding in cirrhosis: varix or no varix?
Topics: Duodenum; Gastrointestinal Hemorrhage; Hepatitis C, Chronic; Humans; Ligation; Liver Cirrhosis; Lypressin; Male; Middle Aged; Terlipressin; Tomography, X-Ray Computed; Varicose Veins; Vasoconstrictor Agents | 2013 |
Worldwide practices for pharmacologic therapy in esophageal variceal hemorrhage.
Topics: Attitude of Health Personnel; Combined Modality Therapy; Esophageal and Gastric Varices; Female; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Health Care Surveys; Hemostasis, Endoscopic; Hospitals, Community; Hospitals, University; Humans; Internationality; Liver Cirrhosis; Lypressin; Male; Octreotide; Professional Practice Location; Terlipressin; Vasoconstrictor Agents | 2014 |
Terlipressin-induced hyponatremic encephalopathy in a noncirrhotic patient.
Topics: Adult; Brain Diseases; Female; Humans; Hyponatremia; Liver Cirrhosis; Lypressin; Terlipressin | 2013 |
Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome.
Topics: Bilirubin; Creatinine; Electrocardiography; Fatal Outcome; Hepatorenal Syndrome; Humans; Intestinal Mucosa; Intestines; Liver Cirrhosis; Lypressin; Male; Middle Aged; Necrosis; Terlipressin; Tomography, X-Ray Computed; Vasoconstrictor Agents | 2013 |
Cirrhotic patients with large esophageal varices and older age have poor hemodynamic response to terlipressin.
Topics: Adult; Age Factors; Aged; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Terlipressin; Time Factors; Treatment Outcome; Vasoconstriction; Vasoconstrictor Agents | 2015 |
Terlipressin Induced Severe Hyponatremia.
Topics: Adult; Esophageal and Gastric Varices; Female; Hematemesis; Humans; Hyponatremia; Liver Cirrhosis; Lypressin; Terlipressin; Treatment Outcome; Vasoconstrictor Agents; Water-Electrolyte Imbalance | 2016 |
Management of Hepatorenal Syndrome in the Era of Acute-on-Chronic Liver Failure: Terlipressin and Beyond.
Topics: Acute-On-Chronic Liver Failure; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Terlipressin; Vasoconstrictor Agents | 2016 |
No difference in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding and renal functional impairment.
Topics: Adult; Aged; Databases, Factual; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hospitalization; Humans; Kaplan-Meier Estimate; Kidney Diseases; Liver Cirrhosis; Lypressin; Male; Middle Aged; Retrospective Studies; Somatostatin; Taiwan; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2016 |
Terlipressin, a vasoactive prodrug recommended in hepatorenal syndrome, is an agonist of human V1, V2 and V1B receptors: Implications for its safety profile.
Topics: Animals; Cell Line; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Hepatorenal Syndrome; Humans; Inositol Phosphates; Liver Cirrhosis; Lypressin; Male; Prodrugs; Rats; Rats, Wistar; Receptors, Vasopressin; Terlipressin; Transfection; Vasopressins | 2016 |
[A case of ischemic skin necrosis after glypressin therapy in liver cirrhosis].
Topics: Aged; Fatal Outcome; Hematemesis; Hemorrhage; Humans; Ischemia; Liver Cirrhosis; Lypressin; Male; Melena; Necrosis; Skin; Terlipressin; Vasoconstrictor Agents | 2008 |
Vasoconstrictor therapy for patients with cirrhosis with ascites but without hepatorenal syndrome.
Topics: Adrenergic alpha-Agonists; Ascites; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Midodrine; Terlipressin; Vasoconstrictor Agents | 2008 |
Clinical features and treatment outcomes of upper gastrointestinal bleeding in patients with cirrhosis.
Topics: Adult; Aged; Cohort Studies; Female; Gastrointestinal Hemorrhage; Hemostatic Techniques; Humans; Infections; Liver Cirrhosis; Lypressin; Male; Middle Aged; Terlipressin; Treatment Outcome | 2008 |
Terlipressin in 30 patients with hepatorenal syndrome: results of a retrospective study.
Topics: Adult; Aged; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Liver Transplantation; Lypressin; Male; Middle Aged; Prognosis; Renal Dialysis; Retrospective Studies; Terlipressin; Vasoconstrictor Agents | 2009 |
Prevention of early variceal rebleeding adding banding to terlipressin therapy.
Topics: Aged; Combined Modality Therapy; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Ligation; Liver Cirrhosis; Lypressin; Recurrence; Terlipressin; Vasoconstrictor Agents | 2009 |
Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome.
Topics: Aged; Albumins; Antihypertensive Agents; Blood Pressure; Creatinine; Female; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Predictive Value of Tests; Terlipressin | 2010 |
Terlipressin therapy for renal failure in cirrhosis.
Topics: Adult; Aged; Creatinine; Electrolytes; Female; Hemodynamics; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Multivariate Analysis; Renal Insufficiency; Retrospective Studies; Serum Albumin; Terlipressin; Treatment Outcome; Urea; Vasoconstrictor Agents; Young Adult | 2010 |
Targeting circulatory dysfunction in cirrhosis: terlipressin and the hepatorenal syndrome.
Topics: Hemodynamics; Hepatorenal Syndrome; Humans; Hypertension, Portal; Liver Circulation; Liver Cirrhosis; Lypressin; Renal Circulation; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2009 |
[Type 2 hepatorenal syndrome in a cirrhotic patient who underwent gastric cancer surgery].
Topics: Adult; Hepatitis C; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Male; Portasystemic Shunt, Transjugular Intrahepatic; Stomach Neoplasms; Terlipressin; Tomography, X-Ray Computed; Vasoconstrictor Agents | 2010 |
Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension.
Topics: Adult; Aged; Bilirubin; Creatinine; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Hyponatremia; International Normalized Ratio; Liver Cirrhosis; Lypressin; Male; Middle Aged; Serum Albumin; Sodium; Terlipressin | 2010 |
[54-year-old male with hepatic cirrhosis and therapy-associated torsade de pointes tachycardia].
Topics: Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Terlipressin; Torsades de Pointes; Vasoconstrictor Agents | 2011 |
Terlipressin infusion induces Tako-Tsubo syndrome in a cirrhotic man with hepato-renal syndrome.
Topics: Aged; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Male; Takotsubo Cardiomyopathy; Terlipressin | 2011 |
Diagnosis and therapy of ascites in liver cirrhosis.
Topics: Albumins; Ascites; Ascitic Fluid; Bacterial Infections; Clinical Trials as Topic; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Paracentesis; Peritonitis; Portasystemic Shunt, Transjugular Intrahepatic; Renin-Angiotensin System; Terlipressin | 2011 |
Bacterial translocation attenuates the systemic hemodynamic improvement produced by terlipressin in patients with cirrhosis.
Topics: Bacterial Translocation; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Terlipressin; Vasoconstrictor Agents | 2011 |
Treatment of the hepatorenal syndrome and hyponatremia in cirrhosis - part II.
Topics: Acute Kidney Injury; Clinical Protocols; Contraindications; Diuretics; Evidence-Based Medicine; Fluid Therapy; Hepatorenal Syndrome; Humans; Hyponatremia; Liver Cirrhosis; Lypressin; Renal Insufficiency, Chronic; Terlipressin; Vasoconstrictor Agents; Water-Electrolyte Imbalance | 2012 |
Risk factors for in-hospital mortality in cirrhotic patients with oesophageal variceal bleeding.
Topics: Adult; Aged; Aged, 80 and over; Erythrocyte Transfusion; Esophageal and Gastric Varices; Female; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hospital Mortality; Hospitalization; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Octreotide; Platelet Count; Portugal; Risk Factors; Severity of Illness Index; Terlipressin; Vasoconstrictor Agents | 2012 |
Hepatorenal syndrome: a severe, but treatable, cause of kidney failure in cirrhosis.
Topics: Albumins; Combined Modality Therapy; Follow-Up Studies; Hepatorenal Syndrome; Humans; Kidney Function Tests; Liver Cirrhosis; Liver Function Tests; Liver Transplantation; Lypressin; Male; Middle Aged; Renal Insufficiency; Risk Assessment; Severity of Illness Index; Terlipressin; Treatment Outcome | 2012 |
Terlipressin improves pulmonary pressures in cirrhotic patients with pulmonary hypertension and variceal bleeding or hepatorenal syndrome.
Topics: Antihypertensive Agents; Arterial Pressure; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Greece; Hepatorenal Syndrome; Humans; Hypertension, Pulmonary; Liver Cirrhosis; Lypressin; Male; Terlipressin; Treatment Outcome; Vascular Resistance; Vasoconstrictor Agents | 2012 |
AKI in a patient with cirrhosis and ascites.
Topics: Acute Kidney Injury; Adult; Ascites; Creatinine; Female; Fluid Therapy; Glomerular Filtration Rate; Humans; Hypotension; Hypovolemia; Liver Cirrhosis; Lypressin; Oliguria; Paracentesis; Terlipressin; Vasoconstrictor Agents | 2012 |
Cholesterol metabolism in acute upper gastrointestinal bleeding, preliminary observations.
Topics: Acute Disease; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Combined Modality Therapy; Endoscopy, Gastrointestinal; Erythrocyte Transfusion; Esophageal and Gastric Varices; Female; Fluid Therapy; Follow-Up Studies; Gastrointestinal Hemorrhage; Hematemesis; Hemodilution; Humans; Hypercholesterolemia; Infusions, Intravenous; Intensive Care Units; Liver Cirrhosis; Lypressin; Male; Melena; Middle Aged; Omeprazole; Parenteral Nutrition, Total; Proton Pump Inhibitors; Terlipressin | 2012 |
Terlipressin resolves ascites of cirrhotic rats through downregulation of aquaporin 2.
Topics: Alanine Transaminase; Animals; Aquaporin 1; Aquaporin 2; Arginine Vasopressin; Ascites; Bilirubin; Blood Pressure; Blood Urea Nitrogen; Down-Regulation; Kidney; Liver Cirrhosis; Lypressin; Male; Rats; Rats, Sprague-Dawley; Serum Albumin; Terlipressin; Vasoconstrictor Agents | 2012 |
Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: a retrospective analysis.
Topics: Adult; Female; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Predictive Value of Tests; Prognosis; Retrospective Studies; Severity of Illness Index; Survival Rate; Terlipressin; Vasoconstrictor Agents | 2002 |
Terlipressin and arterial blood volume after paracentesis for tense ascites in cirrhosis.
Topics: Ascites; Humans; Hypovolemia; Liver Cirrhosis; Lypressin; Paracentesis; Terlipressin; Vasoconstrictor Agents | 2002 |
[Comparison of Doppler ultrasonography and hepatic venous pressure gradient in assessing portal hypertension in liver cirrhosis].
Topics: Antihypertensive Agents; Blood Flow Velocity; Female; Hepatic Veins; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Male; Middle Aged; Prospective Studies; Terlipressin; Ultrasonography, Doppler; Venous Pressure | 2002 |
Comparison of Doppler ultrasonography and the hepatic venous pressure gradient in assessing portal hypertension in liver cirrhosis.
Topics: Adult; Aged; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Female; Hepatic Veins; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Male; Middle Aged; Prospective Studies; Pulsatile Flow; Reproducibility of Results; Severity of Illness Index; Terlipressin; Ultrasonography, Doppler; Vascular Resistance | 2003 |
Is spontaneous bacterial peritonitis an inducer of vasopressin analogue side-effects? A case report.
Topics: Aged; Ascites; Bacterial Infections; Dose-Response Relationship, Drug; Fatal Outcome; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Humans; Infusions, Intravenous; Ischemia; Liver Cirrhosis; Lypressin; Male; Peritonitis; Rectum; Serum Albumin; Terlipressin; Vasoconstrictor Agents | 2003 |
Systemic, portal and renal effects of terlipressin in patients with cirrhotic ascites: pilot study.
Topics: Adult; Ascites; Blood Pressure; Cardiac Output; Female; Heart Rate; Hemodynamics; Humans; Kidney; Liver Cirrhosis; Lypressin; Male; Middle Aged; Pilot Projects; Portal System; Statistics, Nonparametric; Terlipressin | 2004 |
Nitric-oxide-lowering effect of terlipressin in decompensated cirrhosis: comparison to the molecular adsorbent recirculating system and correlation with clinical status.
Topics: Aged; Endotoxemia; Humans; Hypotension; Liver Cirrhosis; Liver, Artificial; Lypressin; Male; Nitric Oxide; Sorption Detoxification; Terlipressin; Tumor Necrosis Factor-alpha; Vasoconstrictor Agents; Vasodilation | 2004 |
Inhibition of glucagon improves splanchnic hyporesponse to terlipressin in cirrhotic rats with blood retention in the gastric lumen.
Topics: Animals; Antibodies; Blood; Drug Synergism; Gastric Lavage; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Glucagon; Hypertension, Portal; Liver Cirrhosis; Lypressin; Male; Octreotide; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Stomach; Terlipressin; Vasoconstrictor Agents | 2005 |
Terlipressin avoids hemodialysis in the treatment of refractory hyperkalemia associated with renal dysfunction in cirrhosis.
Topics: Hepatorenal Syndrome; Humans; Hyperkalemia; Liver Cirrhosis; Lypressin; Male; Middle Aged; Renal Agents; Terlipressin | 2005 |
Treatment of hepatic hydrothorax with terlipressin in a cirrhotic patient.
Topics: Albumins; Hepatitis B; Hepatitis D; Humans; Hydrothorax; Liver Cirrhosis; Lypressin; Male; Middle Aged; Terlipressin; Vasoconstrictor Agents | 2006 |
Recent variceal bleeding: Doppler US hepatic vein waveform in assessment of severity of portal hypertension and vasoactive drug response.
Topics: Antihypertensive Agents; Esophageal and Gastric Varices; Female; Hepatic Veins; Humans; Hypertension, Portal; Liver Cirrhosis; Logistic Models; Lypressin; Male; Middle Aged; Monitoring, Physiologic; Portal Pressure; Prognosis; Prospective Studies; Sensitivity and Specificity; Terlipressin; Ultrasonography, Doppler | 2006 |
Hemodynamic effects of terlipressin in patients with bleeding esophageal varices secondary to cirrhosis of liver.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Pulse; Terlipressin; Vasoconstrictor Agents | 2006 |
An economic evaluation of vasoactive agents used in the United Kingdom for acute bleeding oesophageal varices in patients with liver cirrhosis.
Topics: Cost-Benefit Analysis; Drug Costs; Esophageal and Gastric Varices; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Lypressin; Octreotide; Terlipressin; United Kingdom; Vasoconstrictor Agents | 2007 |
Hemodynamic effects of terlipressin in patients with bleeding esophageal varices secondary to cirrhosis of liver.
Topics: Blood Pressure; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Lypressin; Shock, Septic; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2007 |
Ischaemic complications of Glypressin in liver disease: a case series.
Topics: Female; Humans; Ischemia; Liver Cirrhosis; Lypressin; Male; Middle Aged; Necrosis; Skin; Terlipressin; Vasoconstrictor Agents | 2007 |
Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome.
Topics: Albumins; Female; Hepatorenal Syndrome; Humans; Kidney Function Tests; Liver Cirrhosis; Lypressin; Male; Middle Aged; Terlipressin; Time Factors; Vasoconstrictor Agents | 2008 |
Terlipressin infusion induces ischemia of breast skin in a cirrothic patient with hepatorenal syndrome.
Topics: Aged; Breast; Cyanosis; Female; Hepatorenal Syndrome; Humans; Infusions, Intra-Arterial; Ischemia; Liver Cirrhosis; Lypressin; Skin; Terlipressin; Vasoconstrictor Agents | 2008 |
[Recent developments in the medical treatment of emergency cirrhotic hemorrhage. Vasopressin and glipressin, prostaglandins, somatostatin, propranolol, cimetidine and ranitidine].
Topics: Cimetidine; Emergencies; Hemorrhage; Humans; Liver Cirrhosis; Lypressin; Propranolol; Prostaglandins; Ranitidine; Somatostatin; Terlipressin; Vasopressins | 1983 |
Haemostatic effects of lysine vasopressin and triglycyl lysine vasopressin infusion in patients with cirrhosis.
Topics: Antigens; Blood Pressure; Esophageal and Gastric Varices; Factor VIII; Gastrointestinal Hemorrhage; Hemostasis; Humans; Liver Cirrhosis; Lypressin; Plasminogen Activators; Pulse; Terlipressin; Time Factors | 1980 |
Vascular hyporesponsiveness in cirrhosis - many facets of a common problem!
Topics: Animals; Biomechanical Phenomena; Epoprostenol; Hypertension, Portal; Liver Cirrhosis; Lypressin; Models, Biological; Rats; Terlipressin | 2001 |
Life, death, and varices.
Topics: Antibiotic Prophylaxis; Antihypertensive Agents; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Portasystemic Shunt, Transjugular Intrahepatic; Sclerotherapy; Terlipressin; Treatment Outcome | 2001 |
Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study.
Topics: Aged; Antihypertensive Agents; Female; Follow-Up Studies; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Multivariate Analysis; Renal Insufficiency; Retrospective Studies; Survival Analysis; Terlipressin | 2002 |
Effect of terlipressin (Glypressin) on hepatorenal syndrome in cirrhotic patients: results of a multicentre pilot study.
Topics: Aged; Creatinine; Female; Hemodynamics; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Liver Function Tests; Lypressin; Male; Middle Aged; Pilot Projects; Retrospective Studies; Terlipressin; Vasoconstrictor Agents | 2002 |
Systemic and portal haemodynamic changes following triglycyllysine vasopressin plus nitroglycerin administration in patients with hepatitis B-related cirrhosis.
Topics: Adult; Aged; Drug Combinations; Hemodynamics; Hepatitis B; Humans; Injections, Intravenous; Liver; Liver Cirrhosis; Lypressin; Male; Middle Aged; Nitroglycerin; Terlipressin | 1990 |
Haemodynamic effects of triglycyl-lysine vasopressin plus nitroglycerin in patients with HBsAg-positive cirrhosis.
Topics: Drug Synergism; Hemodynamics; Hepatitis B Surface Antigens; Humans; Liver Cirrhosis; Lypressin; Nitroglycerin; Portal System; Terlipressin | 1989 |
[The effect of terlipressin (Remestyp Spofa) on hemodynamic parameters in patients with portal hypertension associated with liver cirrhosis].
Topics: Hemodynamics; Humans; Hypertension, Portal; Liver Cirrhosis; Lypressin; Terlipressin | 1989 |
[Changes in portal hemodynamics during pharmacologic stimulation: somatostatin vs glypressin].
Topics: Blood Pressure; Humans; Liver Cirrhosis; Lypressin; Portal System; Regional Blood Flow; Somatostatin; Terlipressin; Time Factors | 1986 |
[Effect of glycylpressin on pressure in esophageal varices in patients with liver cirrhosis and previous hemorrhaging varices].
Topics: Adult; Aged; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Lypressin; Middle Aged; Pressure; Terlipressin | 1987 |
[Effects of glypressin on the splanchnic and systemic circulation in patients with cirrhosis].
Topics: Adult; Drug Evaluation; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Splanchnic Circulation; Terlipressin | 1985 |